Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Goodwill & Intangibles (2022 - 2025)

Arcutis Biotherapeutics (ARQT) has 4 years of Goodwill & Intangibles data on record, last reported at $14.8 million in Q4 2025.

  • For Q4 2025, Goodwill & Intangibles rose 56.26% year-over-year to $14.8 million; the TTM value through Dec 2025 reached $14.8 million, up 56.26%, while the annual FY2025 figure was $14.8 million, 56.26% up from the prior year.
  • Goodwill & Intangibles reached $14.8 million in Q4 2025 per ARQT's latest filing, down from $15.4 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $16.5 million in Q1 2025 and bottomed at $6.1 million in Q2 2024.
  • Average Goodwill & Intangibles over 4 years is $9.9 million, with a median of $7.4 million recorded in 2022.
  • Peak YoY movement for Goodwill & Intangibles: dropped 10.71% in 2024, then soared 164.0% in 2025.
  • A 4-year view of Goodwill & Intangibles shows it stood at $7.2 million in 2022, then fell by 10.43% to $6.4 million in 2023, then surged by 47.24% to $9.5 million in 2024, then skyrocketed by 56.26% to $14.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $14.8 million in Q4 2025, $15.4 million in Q3 2025, and $15.9 million in Q2 2025.